Noah Clauser Net Worth

Noah Clauser biography

Noah Clauser serves as Chief Financial Officer of the Company. He had served as the Company’s Vice President, Finance since August 2017, leading the Company’s finance and operations functions. Previously, he served as Senior Director, Finance and Controller of the Company from January 2016 to August 2017 and as Controller of the Company from April 2011 to December 2015. Mr. Clauser is a licensed Certified Public Accountant in Massachusetts and holds an M.S. in Accounting and a B.S. in Management from the University of Massachusetts at Boston.

How old is Noah Clauser?

Noah Clauser is 47, he's been the Chief Financial Officer of Astria Therapeutics Inc since 2020. There are 10 older and no younger executives at Astria Therapeutics Inc. The oldest executive at Astria Therapeutics Inc is Michael Kishbauch, 71, who is the Independent Director.

What's Noah Clauser's mailing address?

Noah's mailing address filed with the SEC is C/O CATABASIS PHARMACEUTICALS, INC.,, 100 HIGH STREET, FLOOR 28, BOSTON, MA, 02110.

Insiders trading at Astria Therapeutics Inc

Over the last 9 years, insiders at Astria Therapeutics Inc have traded over $0 worth of Astria Therapeutics Inc stock and bought 3,064,797 units worth $36,777,564 . The most active insiders traders include Jean George, Nicholas Galakatos oraz Lifesciences Ii, L.P.Clarus.... On average, Astria Therapeutics Inc executives and independent directors trade stock every 0 days with the average trade being worth of $2,617,339. The most recent stock trade was executed by Lifesciences Ii, L.P.Clarus... on 30 June 2015, trading 376,695 units of CATB stock currently worth $4,520,340.

What does Astria Therapeutics Inc do?

Astria Therapeutics Inc executives and stock owners

Astria Therapeutics Inc executives and other stock owners filed with the SEC include:

• Jill Milne,
  President, Chief Executive Officer, Co-Founder, Director
• Joanne Donovan,
  Chief Medical Officer
• Andrew Nichols,
  Chief Scientific Officer
• Kenneth Bate,
  Independent Chairman of the Board
• Michael Kishbauch,
  Independent Director
• Gregg Lapointe,
  Independent Director
• Burt Adelman,
  Independent Director
• Hugh Cole,
  Independent Director
• Joanne Beck,
  Independent Director
• Andrew Komjathy,
  Chief Commercial Officer
• Benjamin Harshbarger,
  Senior Vice President, General Counsel
• Noah Clauser,
  Chief Financial Officer
• Andrea Matthews,
  IR Contact Officer
• Rick Modi,
  Chief Business Officer
• Jean George,
  Director
• V, Llcsv Life Sciences Fund...,
  
• Ron Laufer,
  Director
• Michael Jay Ross,
  Director
• Michael Jirousek,
  Chief Scientific Officer
• Lifesciences Ii, L.P.Clarus...,
  
• Ian C. Sanderson,
  Chief Financial Officer
• Ventures, Inc. Med Immune,
  10% owner
• Nicholas Galakatos,
  Director
• Edward K. Hibben,
  Chief Business Officer
• Fred Callori,
  Director
• Jonathan Violin,
  Director
• Deirdre A. Cunnane,
  Chief Legal Officer
• Advisors Llcperceptive Life...,